ATAD1 and parasitic infectious disease: In agreement with the above data suggesting a more substantial immunogenicity for MSP119 than AMA1 in the context of parasite infection, the resting mBC level approximately 3 months post-drug treatment was significantly higher only for MSP1-vaccinated volunteers in comparison to vaccination only responses at the most similar time-point.